A brief history of taxol

Justyna Żwawiak, Lucjusz Zaprutko

Abstract


Traditional application of plant in folk medicine is a base for discovery of new active chemical substances. In the second half of 20th century, significant antitumor activity of extract from bark of the Yew tree was recognized. The compound that was responsible for this kind of properties has called taxol and had structure of diterpene with acyl groups. Low availability forced researchers to find different ways of taxol gaining. In the further years, many synthetic and semi-synthetic methods were developed. Nowadays, biotechnological methods with use of cell suspension cultures are introduced.

Keywords


cancer; taxol; chemotherapy

Full Text:

PDF

References


Cravotto G, Boffa L, Genziniand L, Garella D. Phytotherapeutics: an evaluation of the potential of. 1000 plants. J Clin Pharm Ther. 2010 Feb;35:11–48.

Pieters L, Vlietinck AJ. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds. J Ethnopharm. 2005 Aug;100:57–60.

Głowniak K, Skalicka-Woźniak K, Widelski J. Wyciśnięte z cisa... Panacea. 2013 Apr-Jun;26–27.

Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents: VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May;93:2325–2327.

Samaranayake G, Neidigh KA, Kingston DG. Modified taxols. 8. Deacylation and reacylation of baccatin III. J Nat Prod. 1993 Jun;56(6):884–898.

Holton RA, Somoza C, Kim HB, Liang F, Biediger RJ, Boatman PD et al. First total synthesis of taxol. 1. Functionalization of the B ring. J Am Chem Soc. 1994 Feb;116:1597–1598.

Nassar SA, El-Ahmady SH, Nassar AH, Al-Azizi MM. Studying the possible biotransformation of the cytotoxic diterpenoid paclitaxel using Jatropha Curcas cell suspension culture. Eur J Med Plants. 2013 Mar;3(2):241–253.

Venilla R, Muthumary J. Taxol from Pestalotiopsis pauciseta VM1, an endophytic fungus of Tabebuia pentaphylla. Biomed Prev Nutr. 2011 Jan;1:103–108.

Zhao Y, Yu RM, Schroeder C, Sadler I, Unger M, Sun XF et al. Biotransformation of paclitaxel (taxol) by the cell suspension cultures of Rauwolfia serpentina. Acta Bot Sin. 2004 Jun;46(11):1383–1386.

Szoka Ł. Metody biotechnologiczne w otrzymywaniu taksolu – cytostatycznego diterpenu cisów (Taxus). Gazeta Farmaceutyczna. 2009 Sep;9:34–36.

Hamada H, Sanada K, Furuya T, Kawabe S, Jaziri M. Biotransformation of paclitaxel by cell suspension cultures of Eucalyptus perriniana. Nat Prod Lett. 1996 Jan;9(1):47–52.

Sanada K, Kawaguchi A, Furuya T, Hamada H. Biotransformation of paclitaxel by cell suspension cultures of Marchantia polymorpha. Plant Biotechnol. 2000 Jul;17(4):321–323.

Fu Y, Li S, Zu Y, Yang G, Yang Z, Luo M et al. Medicinal chemistry of paclitaxel and its analogues. Curr Med Chem. 2009 Sep;16(30):3966–3985.

Kingston DGI. The shape of things to come: Structural and synthetic studies of taxol and related compounds. Phytochem. 2007 Dec;68:1844–1854.

Huttel MS, Olesen AS, Stoffersen E. Complement – mediated reactions to diazepam with Cremophor as solvent (Stesolic MR). Br J Anaesth. 1980 Jan;52:77–79.

Bamburowicz-Klimkowska M, Szutowski MM. Strategie walki ze zjawiskiem oporności wielolekowej nowotworów. Biul Wydz Farm. WUM 2012 Mar;1:1–8.

Priyadarshini K, Keerthi Aparajitha U. Paclitaxel against cancer: a short review. Med Chem. 2012 Nov;2(7):139–141.

Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2007 Aug;3:1341–1346.

Sobhani Z, Dinarvand R, Atyabi F, Ghahremani M, Adeli M. Increased paclitaxel cytotoxity against cancer cell lines using a novel functionalized carbon nanotube. Int J Nanomedicine. 2011 Apr;6:705–719.

Hoang B, Ekdawi SN, Reilly RM, Allen C. Active targeting of block copolymer micelles with Trastuzumab Fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER 2 – overexpressing Xenografts. Mol. Pharmaceutics. 2013 Sep;10(11):4229–4241.

Wartlick H, Spankuch-Schmitt B, Strebhardt K, Kreuter J, Langer K. Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticles. J Control Rel. 2004 May;96:483–495.

Kontermann RE. Immunoliposomes for cancer therapy. Curr Op Mol Ther. 2006 Feb;8:39–45.

Colin M, Guenard D, Gueritte-Voegelein F, Potier P. Eur Pat Appl. 1988 Jan; EP 253,738.

Magri NF, Kingston DGI. Modified taxols. 4. Synthesis and biological activity of taxols modified in the side chain. J Nat Prod. 1988 Mar-Apr;51(2):298–306

Tabaczar S, Koceva-Chyła A, Matczak K, Gwoździński K. Molekularne mechanizmy aktywności przeciwnowotworowej taksanów. I. Oddziaływanie docetakselu na mikrotubule. Postępy Hig Med Dośw. 2010 Nov;64:568–581

Dieras V, Limentani S, Romieu G, Tubiana-Hulin M, Lortholary A, Kaufman P et al. Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane – based therapy. Ann Oncol. 2008 Jul;19(7):1255–1260.

Cheetham P, Petrylak DP. Tubulin – targeted agents including docetaxel and cabazitaxel. Cancer J. 2013 Jan; 19(1): 59–65.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Medical Science

Copyright 2018 by Journal of Medical Sciences